Neuromuscular Blocking Agent (NMBA) Market Report

Global and Region Neuromuscular Blocking Agent (NMBA) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：173
  • REPORT CODE：GMM898068
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Neuromuscular Blocking Agent (NMBA) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Neuromuscular Blocking Agent (NMBA)market, defines the market attractiveness level of Neuromuscular Blocking Agent (NMBA) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Neuromuscular Blocking Agent (NMBA) industry, describes the types of Neuromuscular Blocking Agent (NMBA) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neuromuscular Blocking Agent (NMBA) market and the development prospects and opportunities of Neuromuscular Blocking Agent (NMBA) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neuromuscular Blocking Agent (NMBA) market in Chapter 13.

    By Player:

    • GlaxoSmithKline

    • Themis Medicare

    • Shanghai Pharmaceuticals

    • Hengrui Pharmaceutical

    • Pfizer

    • Sandoz

    • Nanjing King-Friend

    • Somerset Therapeutics

    • Fresenius Kabi

    • Abbott Laboratories

    • AbbVie

    • Guike Pharmaceutical

    By Type:

    • Depolarizing

    • Non-depolarizing

    By End-User:

    • Hospital

    • Clinic

    • Pharmacy

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Neuromuscular Blocking Agent (NMBA) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Neuromuscular Blocking Agent (NMBA) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Neuromuscular Blocking Agent (NMBA) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Neuromuscular Blocking Agent (NMBA) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Neuromuscular Blocking Agent (NMBA) Market Analysis and Outlook to 2022

    • 7.1 Global Neuromuscular Blocking Agent (NMBA) Consumption (2017-2022)

    • 7.2 United States Neuromuscular Blocking Agent (NMBA) Consumption (2017-2022)

    • 7.3 Europe Neuromuscular Blocking Agent (NMBA) Consumption (2017-2022)

    • 7.4 China Neuromuscular Blocking Agent (NMBA) Consumption (2017-2022)

    • 7.5 Japan Neuromuscular Blocking Agent (NMBA) Consumption (2017-2022)

    • 7.6 India Neuromuscular Blocking Agent (NMBA) Consumption (2017-2022)

    • 7.7 South Korea Neuromuscular Blocking Agent (NMBA) Consumption (2017-2022)

    8 Region and Country-wise Neuromuscular Blocking Agent (NMBA) Market Analysis and Outlook to 2028

    • 8.1 Global Neuromuscular Blocking Agent (NMBA) Consumption Forecast (2022-2028)

    • 8.2 United States Neuromuscular Blocking Agent (NMBA) Consumption Forecast (2022-2028)

    • 8.3 Europe Neuromuscular Blocking Agent (NMBA) Consumption Forecast (2022-2028)

    • 8.4 China Neuromuscular Blocking Agent (NMBA) Consumption Forecast (2022-2028)

    • 8.5 Japan Neuromuscular Blocking Agent (NMBA) Consumption Forecast (2022-2028)

    • 8.6 India Neuromuscular Blocking Agent (NMBA) Consumption Forecast (2022-2028)

    • 8.7 South Korea Neuromuscular Blocking Agent (NMBA) Consumption Forecast (2022-2028)

    9 Global Neuromuscular Blocking Agent (NMBA) Market Outlook by Types and Applications to 2022

    • 9.1 Global Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Depolarizing Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Non-depolarizing Consumption and Growth Rate (2017-2022)

    • 9.2 Global Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Pharmacy Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Neuromuscular Blocking Agent (NMBA) Market Outlook by Types and Applications to 2028

    • 10.1 Global Neuromuscular Blocking Agent (NMBA) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Depolarizing Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Non-depolarizing Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Neuromuscular Blocking Agent (NMBA) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Neuromuscular Blocking Agent (NMBA) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Neuromuscular Blocking Agent (NMBA) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Neuromuscular Blocking Agent (NMBA) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Neuromuscular Blocking Agent (NMBA) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Neuromuscular Blocking Agent (NMBA) Market Competitive Analysis

    • 14.1 GlaxoSmithKline

      • 14.1.1 GlaxoSmithKline Company Details

      • 14.1.2 GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Product and Service

    • 14.2 Themis Medicare

      • 14.2.1 Themis Medicare Company Details

      • 14.2.2 Themis Medicare Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Themis Medicare Neuromuscular Blocking Agent (NMBA) Product and Service

    • 14.3 Shanghai Pharmaceuticals

      • 14.3.1 Shanghai Pharmaceuticals Company Details

      • 14.3.2 Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Product and Service

    • 14.4 Hengrui Pharmaceutical

      • 14.4.1 Hengrui Pharmaceutical Company Details

      • 14.4.2 Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product and Service

    • 14.5 Pfizer

      • 14.5.1 Pfizer Company Details

      • 14.5.2 Pfizer Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Pfizer Neuromuscular Blocking Agent (NMBA) Product and Service

    • 14.6 Sandoz

      • 14.6.1 Sandoz Company Details

      • 14.6.2 Sandoz Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Sandoz Neuromuscular Blocking Agent (NMBA) Product and Service

    • 14.7 Nanjing King-Friend

      • 14.7.1 Nanjing King-Friend Company Details

      • 14.7.2 Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Product and Service

    • 14.8 Somerset Therapeutics

      • 14.8.1 Somerset Therapeutics Company Details

      • 14.8.2 Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Product and Service

    • 14.9 Fresenius Kabi

      • 14.9.1 Fresenius Kabi Company Details

      • 14.9.2 Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Product and Service

    • 14.10 Abbott Laboratories

      • 14.10.1 Abbott Laboratories Company Details

      • 14.10.2 Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Product and Service

    • 14.11 AbbVie

      • 14.11.1 AbbVie Company Details

      • 14.11.2 AbbVie Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 AbbVie Neuromuscular Blocking Agent (NMBA) Product and Service

    • 14.12 Guike Pharmaceutical

      • 14.12.1 Guike Pharmaceutical Company Details

      • 14.12.2 Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Neuromuscular Blocking Agent (NMBA)

    • Figure Neuromuscular Blocking Agent (NMBA) Picture

    • Table Global Neuromuscular Blocking Agent (NMBA) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Neuromuscular Blocking Agent (NMBA) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Neuromuscular Blocking Agent (NMBA) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Neuromuscular Blocking Agent (NMBA) Consumption by Country (2017-2022)

    • Figure United States Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2017-2022)

    • Table Europe Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2017-2022)

    • Figure China Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2017-2022)

    • Figure Japan Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2017-2022)

    • Figure India Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Neuromuscular Blocking Agent (NMBA) Consumption and Growth Rate (2017-2022)

    • Figure Global Neuromuscular Blocking Agent (NMBA) Consumption Forecast by Country (2022-2028)

    • Figure United States Neuromuscular Blocking Agent (NMBA) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Neuromuscular Blocking Agent (NMBA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Neuromuscular Blocking Agent (NMBA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Neuromuscular Blocking Agent (NMBA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Neuromuscular Blocking Agent (NMBA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Neuromuscular Blocking Agent (NMBA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Depolarizing Consumption and Growth Rate (2017-2022)

    • Figure Global Non-depolarizing Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Depolarizing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-depolarizing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Neuromuscular Blocking Agent (NMBA) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Neuromuscular Blocking Agent (NMBA) Export by Region (Top 5 Countries) (2017-2028)

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Product and Service

    • Table Themis Medicare (Foundation Year, Company Profile and etc.)

    • Table Themis Medicare Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Themis Medicare Neuromuscular Blocking Agent (NMBA) Product and Service

    • Table Shanghai Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Product and Service

    • Table Hengrui Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Neuromuscular Blocking Agent (NMBA) Product and Service

    • Table Sandoz (Foundation Year, Company Profile and etc.)

    • Table Sandoz Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sandoz Neuromuscular Blocking Agent (NMBA) Product and Service

    • Table Nanjing King-Friend (Foundation Year, Company Profile and etc.)

    • Table Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Product and Service

    • Table Somerset Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Product and Service

    • Table Fresenius Kabi (Foundation Year, Company Profile and etc.)

    • Table Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Neuromuscular Blocking Agent (NMBA) Product and Service

    • Table Guike Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US